These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29247280)

  • 1. Rothia dentocariosa endophthalmitis following intravitreal injection-a case report.
    Hayes RA; Bennett HY; O'Hagan S
    J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):24. PubMed ID: 29247280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.
    Roth DB; Chieh J; Spirn MJ; Green SN; Yarian DL; Chaudhry NA
    Arch Ophthalmol; 2003 Sep; 121(9):1279-82. PubMed ID: 12963610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CASE REPORT OF ABIOTROPHIA DEFECTIVA ENDOPHTHALMITIS AFTER REPEATED INJECTIONS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX).
    Cruz-Iñigo YJ; Klein K; Reddy RK
    Retin Cases Brief Rep; 2022 Mar; 16(2):170-173. PubMed ID: 31479011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
    Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
    Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute-Onset Endophthalmitis Caused by Alloiococcus otitidis following a Dexamethasone Intravitreal Implant.
    Marchino T; Vela JI; Bassaganyas F; Sánchez S; Buil JA
    Case Rep Ophthalmol; 2013 Jan; 4(1):37-41. PubMed ID: 23626572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Endophthalmitis Caused by
    Singh S; Patel CV; Kishore K
    Case Rep Ophthalmol; 2017; 8(3):510-514. PubMed ID: 29282402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
    Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
    Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms.
    Sachdeva MM; Moshiri A; Leder HA; Scott AW
    J Ophthalmic Inflamm Infect; 2016 Dec; 6(1):2. PubMed ID: 26758203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of endogenous endophthalmitis with extensive subretinal abscess: a case report.
    Xu H; Fu B; Lu C; Xu L; Sun J
    BMC Ophthalmol; 2018 Sep; 18(1):238. PubMed ID: 30185150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster endophthalmitis due to
    Agarwal AK; Aggarwal K; Samanta R; Angrup A; Biswal M; Ray P; Dogra M; Katoch D; Bansal R; Singh R; Dogra MR; Gupta V
    Br J Ophthalmol; 2019 Sep; 103(9):1278-1283. PubMed ID: 30420442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 15. STENOTROPHOMONAS MALTOPHILIA ENDOPHTHALMITIS 1 MONTH AFTER INTRAVITREAL AFLIBERCEPT.
    Boeke PS; Gottlieb JL
    Retin Cases Brief Rep; 2019; 13(4):327-328. PubMed ID: 28358745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes.
    Goldberg RA; Shah CP; Wiegand TW; Heier JS
    Am J Ophthalmol; 2014 Oct; 158(4):733-737.e1. PubMed ID: 24983791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin).
    Georgopoulos M; Polak K; Prager F; Prünte C; Schmidt-Erfurth U
    Br J Ophthalmol; 2009 Apr; 93(4):457-62. PubMed ID: 19033289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous hemorrhage as an early sign of acute bacterial endophthalmitis following intravitreal ranibizumab injection.
    Weill Y; Brosh K; Levi-Vineberg T; Hanhart J
    Int Ophthalmol; 2018 Apr; 38(2):799-802. PubMed ID: 28365853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninfectious endophthalmitis occurring after intravitreal triesence injection.
    Bakri SJ; Edwards AO; Couch SM
    Retin Cases Brief Rep; 2009; 3(3):316-8. PubMed ID: 25389596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitreal surgery and etiological diagnosis of bacterial endophthalmitis].
    Ye JJ; Guo LB; Wang SR; Wang WW; Min HY
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):995-1000. PubMed ID: 23302273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.